Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease (Q46691979)

24 December 2017

title

Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease (English)

1 reference

24 December 2017

1 reference

Haas RH

1

1 reference

24 December 2017

Nasirian F

2

1 reference

24 December 2017

Nakano K

3

1 reference

24 December 2017

Ward D

4

1 reference

24 December 2017

Pay M

5

1 reference

24 December 2017

Hill R

6

1 reference

24 December 2017

Shults CW

7

1 reference

24 December 2017

publication date

1 June 1995

1 reference

24 December 2017

published in

Annals of Neurology

1 reference

24 December 2017

volume

37

1 reference

24 December 2017

page(s)

714-722

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

A clinical genetic study of Parkinson's disease: evidence for dominant transmission

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Neuroleptic medications inhibit complex I of the electron transport chain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Energy metabolism of blood platelets. I. Isolation and properties of platelet mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

No evidence for altered muscle mitochondrial function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410370604

21 January 2018

Identifiers

DOI

10.1002/ANA.410370604

1 reference

24 December 2017

PubMed ID

7778844

1 reference

24 December 2017